tiprankstipranks
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market
Want to see EVFM full AI Analyst Report?

Evofem Biosciences (EVFM) Financial Statements

1,206 Followers

Evofem Biosciences Financial Overview

Evofem Biosciences's market cap is currently $887.95K. The company's EPS TTM is $-0.002; its P/E ratio is 0.11; Evofem Biosciences is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 20.18M$ 19.36M$ 18.22M$ 16.84M$ 8.24M
Gross Profit$ 15.07M$ 15.53M$ 11.71M$ 12.42M$ 4.19M
Operating Income$ 1.44M$ -7.68M$ -17.85M$ -84.12M$ -166.80M
EBITDA$ 2.06M$ -6.92M$ -16.07M$ -82.08M$ -165.78M
Net Income$ 391.00K$ -8.86M$ 52.98M$ -76.70M$ -205.19M
Balance Sheet
Cash & Short-Term Investments$ 578.00K$ 741.00K$ 580.00K$ 2.77M$ 7.73M
Total Assets$ 20.27M$ 23.79M$ 10.55M$ 25.16M$ 42.51M
Total Debt$ 65.87M$ 45.97M$ 43.37M$ 71.13M$ 115.68M
Net Debt$ 65.29M$ 45.97M$ 43.37M$ 68.36M$ 107.95M
Total Liabilities$ 89.71M$ 95.05M$ 77.06M$ 96.96M$ 142.09M
Stockholders' Equity$ -69.44M$ -71.26M$ -66.51M$ -71.80M$ -99.58M
Cash Flow
Free Cash Flow$ -2.00M$ -3.90M$ -8.97M$ -70.75M$ -149.61M
Operating Cash Flow$ -1.99M$ -3.88M$ -8.97M$ -70.41M$ -146.67M
Investing Cash Flow$ -62.00K$ -569.00K$ -4.00K$ -341.00K$ -2.69M
Financing Cash Flow$ 1.89M$ 4.62M$ 4.78M$ 61.94M$ 90.69M
Currency in USD

Evofem Biosciences Earnings and Revenue History

Evofem Biosciences Debt to Assets

Evofem Biosciences Cash Flow

Evofem Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.